TELA Bio
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Pennsylvania, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1 Great Valley Pkwy Ste 24, Malvern, Pen...Phone Number
(484) 320-2930Website
www.telabio.comRevenue
$80.8 MillionStock Symbol
TELAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About TELA Bio
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The Company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery.Explore more
TELA Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TELA Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if TELA Bio had a recent Job posting/layoffs
Check if TELA Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if TELA Bio is spiking on competitors!
TELA Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once TELA Bio has new funding data
Earning: See what the market has to say on TELA Bio recently announced quarterly report
Product Launch: Get notified when TELA Bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at TELA Bio
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to TELA Bio
Compare insights from companies similar to TELA Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
TELA Bio
$80.8M
201-500
Public
$237.6M
2012
RC
Roberto CucaChief Operating Officer & Chief Financial Officer
Company Profile Activity
Activity Insights
TELA Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TELA Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TELA Bio.
TELA Bio financials insights
Gather financial insights about TELA Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Unspecified
$6M
2014
Unspecified
$45.4M
Unspecified
$500K
2017
Unspecified
$7.5M
2018
Corporate Investment
$1M
Unspecified
$501K
2019
Unspecified
$10.6M
Stock Offering
$52M
2020
Stock Offering
$48M
2022
Debt
$50M
TELA Bio Tech Stack
A closer look at the technologies used by TELA Bio
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
TELA Bio News & Media
TELA Bio Reports First Quarter 2026 Financial Results
MALVERN, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the first quarter ended March 31, 2026.TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 89,250 shares of its common stock to 12 newly-hired employees, with a grant date of May 5, 2026 (the "Grant Date"). The restricted stock units weTELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced a comprehensive board refreshment plan designed to support the Company’s next phase of commercial growth and operational excellence.TELA Bio to Announce First Quarter 2026 Financial Results
MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2026 financial results on Tuesday, May 12, 2026. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TELA Bio
Sign Up For FreeTo access detailed company insights
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The Company is committed to providing patients with advanced, economically effective biologic material repair solutions to mini... Read More
